1. Introduction {#sec1}
===============

Postural instability is a frequent and incapacitating symptom of Parkinson\'s disease (PD) and is only modestly responsive to pharmacotherapy \[[@B1]\]. As a result, patients must often resort to the use of attentional strategies such as mentally rehearsing action sequences, or consciously attending to their balance, to maintain equilibrium \[[@B2], [@B3]\]. The role of attention in PD has often been investigated within a dual-task paradigm; a methodology which requires participants to perform a primary task (e.g., postural control) while simultaneously performing a secondary task, which may be cognitive (e.g., speech) or motoric (e.g., carrying an object).

Despite the considerable research that has evaluated the impact of dual-task interference on gait and upper extremity performance \[[@B4]\], few studies have examined the effects of dual-task performance on posture, among individuals with PD.

Early work in this area employed clinically relevant measurements, rather than biomechanical assessments. Smithson et al. \[[@B3]\] evaluated standing balance in a sample of individuals with PD, both with and without the addition of a motoric secondary task (self-initiated movements, including arm raise, functional reach, and bend reach). Results suggested that postural instability was greatest among individuals with PD and also that this instability increased with the addition of a secondary task. Morris et al. \[[@B5]\] measured the effect of dual-task interference on postural stability, using a combination of motoric secondary tasks similar to those used by Smithson et al. \[[@B3]\] and a cognitive secondary task (reciting the days of the week backwards). Like Smithson et al. \[[@B3]\], Morris et al. \[[@B5]\] identified greater postural disturbances among individuals with PD and found that both motoric and cognitive secondary tasks produced a significant deterioration in performance, as compared with healthy age-matched controls. In both of these studies, a stopwatch was used to record the time to postural instability, defined as a change in stance position, or a demonstrable need for external support.

Later research employed a more rigorous biomechanical approach, in all cases utilizing a force platform to quantify postural instability. Secondary tasks included color judgment \[[@B6]\], sequential finger movement, and arithmetic calculation \[[@B7]\], and a visuospatial cognitive task \[[@B8]\]. In all three of these studies, secondary task interference produced significantly greater postural change among individuals with PD, as compared with healthy age-matched controls.

Although these studies have contributed to our understanding of the effects of a secondary task on postural stability in people with PD, the impact of cognitively demanding tasks on postural stability is of sufficient interest to warrant further study. In this study, we will evaluate the following hypotheses:

1.  individuals with PD will exhibit more dual-task interference than control participants;

2.  that as the complexity of the secondary task increases, the effects of dual-task interference will be more pronounced on measures of postural instability.

2. Methods {#sec2}
==========

2.1. Participants {#sec2.1}
-----------------

Twelve participants with a clinical diagnosis of idiopathic Parkinson\'s disease (eight men), and 12 age-matched controls (eight men) participated in this study. Individuals with PD were recruited voluntarily from a movement disorders clinic in Southwestern Ontario. Control participants were recruited from within the PD community, and were (in some cases), care partners, family members, or friends of clinical participants.

Participants were between the ages of 50 and 80, and there were no significant age differences between groups (PD: [M]{.ul}  = 64.00, [SD]{.ul}  = 9.08; Control: [M]{.ul}  = 62.67, [SD]{.ul}  = 8.11). Participants were excluded from the study if they were experiencing any neurological (other than PD), cognitive, or motoric impairments that might impact on speech, mobility, or cognition. Additionally, individuals with a Modified Hoehn and Yahr score greater than 3 were excluded from the study, as these individuals have (by definition) difficulty standing without assistance, and were considered to present an unacceptable risk of falling. Participants with PD were evaluated on [Section 3](#sec3){ref-type="sec"} of the Unified Parkinson Disease Rating Scale, and this clinical measure was undertaken by a neurologist specializing in movement disorders. All evaluations were done by the same individual. This clinical information is presented in [Table 1](#tab1){ref-type="table"}, along with relevant demographic information.

2.2. Procedure {#sec2.2}
--------------

Participants with Parkinson\'s disease were tested during their self-determined peak, or "ON", phase of their medication cycle. To help ensure that all participants were within their "ON" phase, testing was conducted approximately two hours after individuals took their usual medications, per the recommendations of Gauntlett-Gilbert and Brown \[[@B9]\]. Participants were asked to stand on the force platform, using a comfortable stance. This stance was then traced on a piece of clear plastic, and this tracing was used to reposition the feet for each subsequent trial. These tracings were then measured to assess stance length and width.

Each participant completed six 30-second trials on the force platform---two trials within each of three experimental conditions. Postural stability of each participant was evaluated with their eyes open under conditions of increasing complexity: (1) no secondary task; (2) while performing a numerical recitation task (counting from one to five in a looped sequence); (3) while engaging in a monologue (describing a familiar place). Trials were averaged within each condition for all data analyses that follow. To minimize the likelihood that participants would become familiar with the speech tasks, practice trials were prohibited.

The research protocol, recruitment method, and mechanism for obtaining informed consent were approved by the Health Sciences Research Ethics Board, at the University of Western Ontario (review \#11940 E).

2.3. Apparatus {#sec2.3}
--------------

Kinetic variables were collected using a model OR6-5 biomechanics platform (Advanced Mechanical Technology Inc., Watertown, USA), oriented so that the x-axis aligned in the direction of forward stance. Custom software was designed, using the sensitivity matrix (S~ij~) provided by the company. Accuracy was re-established at the outset of the experiment, by applying known weights in specific locations on the force platform. Calibration data were collected, and it was determined that the known input was matched by the output of the programs, thus ensuring true information was gathered using the force platform. Force components in the 3 principal axes (anterior-posterior, medial-lateral, and vertical) and moments about these axes were collected at 100 Hz \[[@B10]\].

2.4. Outcome Measures {#sec2.4}
---------------------

The following outcome parameters were used as measures of postural stability.

1.  Total length of the centre of pressure path in the horizontal plane on the force plate (COPL).

2.  Maximal medial lateral COP excursion range, expressed as a percentage of the base of support (%BOSml), where base of support was defined as width of stance.

3.  Maximal anterior posterior COP excursion range, expressed as a percentage of the base of support (%BOSap), where base of support was defined as length of stance.

A schematic representation of these variables is presented in [Figure 1](#fig1){ref-type="fig"}.

2.5. Statistical Analysis {#sec2.5}
-------------------------

To evaluate the influence of dual-task performance on spontaneous centre of pressure excursion, a repeated measures split-plot analysis of variance was performed for each of the dependent variables (COPL, %BOSml, and %BOSap). For each of these analyses, the within-subject factor was "cognitive complexity" with 3 levels (Baseline, Numerical Recitation, and Monologue), and the between-subject factor was "participant group" with 2 levels. Reverse Helmert contrasts were used to elucidate significant effects of the interaction between group and task. This type of contrast allows for a post-hoc assessment of significant effects, by comparing each subsequent level with the average of the previous levels (i.e., "Low Complexity" is compared with "Baseline", and "High Complexity" is compared with the average of "Baseline" and "Low Complexity"). In effect, this provides a means of evaluating the contribution of each increase in cognitive complexity within the secondary task. All statistical calculations are accompanied by estimates of effect size, calculated as an eta-square.

3. Results {#sec3}
==========

The means and standard deviations for each dependent variable, separated by group, are presented in [Table 2](#tab2){ref-type="table"}. A significant multivariate effect was found for the condition by group interaction (*F*(6,17) = 3.535, *P* = .019, *η* ^2^ = 0.55), suggesting that the interaction between condition and group predicts 55% of the variability in postural stability (as measured by an optimally weighted composite of the three dependent variables). Univariate testing suggested a statistically significant interaction between condition and group for all three dependent measures: COPL (*F*(2,44) = 15.518, *P* = .001, *η* ^2^ = 0.165); %BOSap (*F*(2,44) = 3.325, *P* = .045, *η* ^2^ = 0.0929); and %BOSml (*F*(2,44) = 5.228, *P* = .009, *η* ^2^ = 0.141). This suggests that the percentage of variance accounted for by the interaction between condition and group was 16.5% for COPL, 9.29% for %BOSap, and 14.1% for %BOSml. Evaluation of the reverse-Helmert contrasts suggested that only the most complex of the secondary cognitive tasks (i.e., conversational monologue) produced a significant amount of dual-task interference as compared with quiet stance and numerical recitation. These contrasts are summarized in [Figure 2](#fig2){ref-type="fig"}. Interestingly, individuals with Parkinson\'s disease showed significantly less excursion along both anterior-posterior and medial lateral axes, and demonstrated a significantly smaller centre-of-pressure pathway during the most complex task. These contrasts are also summarized in [Figure 2](#fig2){ref-type="fig"}.

4. Discussion {#sec4}
=============

Consistent with previous research, this study demonstrates a significant effect of cognitive load on postural stability \[[@B7], [@B8], [@B11], [@B12]\]. In general, dual-task interference produced increased excursion of the centre of pressure, and this effect became more pronounced with increases in task complexity. Conversely, these data demonstrated a paradoxical effect among participants with Parkinson\'s disease. In keeping with previous research, tasks of low complexity result in an increased excursion of the centre of pressure, across all participants. This effect is, however, reversed on tasks of high complexity. With high complexity, participants with Parkinson\'s disease demonstrate reduced excursion, relative to the healthy age-matched controls. This effect is statistically significant along both axes (anterior-posterior and medial-lateral), and for the length of the centre of pressure pathway.

This suggests that participants with Parkinson\'s disease may be overconstraining their postural adjustments. Given that the overconstraint occurred under conditions of increased cognitive load, it is conceivable that individuals with Parkinson\'s disease were overconstraining their posture in order to focus attention on the cognitive tasks without losing their balance. Their posture was, therefore, stabilized beyond normal levels, in an attempt to prevent threats to balance that may occur when cortical resources are directed to the cognitive tasks. In other words, the patients "prepared themselves" prior to the performance of the cognitive task, by stabilizing to a greater extent than the healthy older controls. Ironically, this overconstraint (which may be undertaken by participants as a consequence of an elevated fear of falling) places the participant at greater risk for a fall.

Although studies of dual-task interference have not reported this overconstraining effect, previous research has demonstrated that individuals with Parkinson\'s disease have decreased excursion in the anterior-posterior during quiet stance, as compared with age-matched controls \[[@B13]\].

A "posture-first principle" has been proposed to account for changes in posture under dual-task conditions, wherein the individual copes with complex situations by prioritizing balance over other concurrent tasks \[[@B14]\]. In the current study, individuals with Parkinson\'s disease applied the "posture-first principle" to a pathological level by overconstraining their postural adjustments. Overconstraint results in reduced proprioceptive feedback, and may theoretically increase co-contraction, both of which diminish the individual\'s ability to respond to unexpected perturbations of balance. Consequently, this strategy for coping with dual-task interference places an individual with Parkinson\'s disease at a greater risk for falls when in a community setting.

5. Conclusions {#sec5}
==============

These results suggest an important new direction for research within the dual-task paradigm. The maladaptive strategy implemented by individuals with Parkinson\'s disease may be addressed with meta-cognitive training that focuses on the development of a more appropriate posture-first strategy.

![Schematic representation of postural variables.](PD2010-696492.001){#fig1}

![Graphical representation of group by task interaction, across all postural variables; \*indicates significantly different from no speech task and numerical recitation see also [Table 2](#tab2){ref-type="table"}.](PD2010-696492.002){#fig2}

###### 

Clinical features of individuals with Parkinson\'s disease.

  Subject              Gender    Age (y)   Duration of Illness (y)   Hoehn & Yahr   UPDRS III   Medication              Dosage total/day
  -------------------- --------- --------- ------------------------- -------------- ----------- ----------------------- ------------------
  PD1                  Female    67        2                         1.5            19          None                    ---
  PD2                  Male      78        8                         2.5            36          Levodopa/Carbidopa      650 mg
  Pramipexole          2.25 mg                                                                                          
  PD3                  Male      69        3                         2.0            23          Levodopa/Carbidopa      350 mg
  PD4                  Male      58        4                         2.5            24          Pramipexole             1.5 mg
  PD5                  Female    50        9                         2.5            20          Levodopa/Carbidopa      400 mg
  Ropinirole           9.5 mg                                                                                           
  PD6                  Male      60        2                         1.5            17          Pramipexole             1.5 mg
  PD7                  Female    76        3                         2.5            26          Levodopa/Carbidopa CR   400 mg
  PD8                  Male      59        5                         2.0            26          Levodopa/Carbidopa      300 mg
  Pramipexole          3.0 mg                                                                                           
  PD9                  Male      49        4                         2.0            28          Ropinirole              12.0 mg
  PD10                 Female    67        8                         2.0            21          Levodopa/Carbidopa CR   200 mg
  Levodopa/Carbidopa   200 mg                                                                                           
  PD11                 Male      67        6                         2.5            21          Levodopa/Carbidopa      1000 mg
  Pramipexole          2.0 mg                                                                                           
  PD12                 Male      68        5                         2.0            28          Levodopa/Carbidopa      400 mg
  Pramipexole          0.75 mg                                                                                          
  Entacapone           800 mg                                                                                           
                       Mean      64.00     4.92                      2.13           24.08       ---                     ---
                       (SD)      (9.08)    (2.39)                    (0.38)         (5.16)                              

###### 

Means (and standard deviations) for each postural variable, separated by group.

  Healthy older adults                               
  ---------------------- ------------- ------------- --------------
                         COPL (m)      BOSml (%)     BOSap (%)
  No task                0.79 (0.11)   3.71 (1.32)   8.74 (2.55)
  Numerical recitation   0.94 (0.15)   4.23 (1.52)   9.31 (3.11)
  Monologue              1.26 (0.23)   7.35 (4.19)   14.0 (6.52)
                                                     
  Parkinson\'s disease                               
                                                     
                         COPL (m)      BOSml (%)     BOSap (%)
                                                     
  No task                0.65 (0.11)   4.11 (2.57)   8.16 (2.07)
  Numerical recitation   0.76 (0.16)   5.21 (3.87)   9.54 (3.36)
  Monologue              0.82 (0.16)   5.11 (3.03)   10.20 (3.85)

Where COPL = length of centre of pressure path; BOSml = medial-lateral centre of pressure excursion range; BOSap = anterior-posterior centre of pressure excursion range.

[^1]: Academic Editor: Peter Hagell
